definiens: means the total costs incurred by the Parties in t he course of planning, conducting, managing or reviewing the results of a Phase I Trial or a Phase II Trial for any Co - Develo ped Product in its Co - Developed Territory, including ( w ithout limitation ): ( a ) costs of producing bulk dru g, filling and finishing, shipping, storing and administering all doses of such Co - Developed Product that are adm inistered to patients during such trials ( where such costs ar e allocated on a per gram basis ), ( b ) payments made to hospitals, medical personnel and clinical trial man agement organizations in consideration for work per formed on such trials, ( c ) costs incurred as a result of the preparation, review and filing of regulatory submis sions for such clinical trials, and ( d ) wages and benefits to the extent employees work on such clinical trials and related regulatory submissions ( calculated on a full - time e quivalent basis ), provided that such costs were inc urred in accordance with each Party ’s responsibilities under the Development Plan for such Co - Developed Product